Browse diseases

…Introduction Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, fatal motor neuron disease. Dia…

…several studies suggesting a potential oligogenic risk model in amyotrophic lateral sclerosis (ALS), case–control statistical evidence implicating oligogenic…

…o-ocular reflex (VOR) characteristics in patients with definite amyotrophic lateral sclerosis (ALS) using 3-dimetional video-head impulse testing (v-HIT) and…

…Amyotrophic lateral sclerosis (ALS) is a motor neuron disease (MND) characterised by progress…

…al magnetic stimulation (TMS) is a valuable diagnostic tool for amyotrophic lateral sclerosis (ALS). Recently, various tracking paradigms have been proposed.…

…in upper and lower limb CSP latency and duration in people with amyotrophic lateral sclerosis (ALS).Methods We recorded CSP latency and duration in people wi…

…n occupational exposure to chlorinated solvents and the risk of amyotrophic lateral sclerosis (ALS) have shown inconsistent results. We aim to examine the as…

…Purpose Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative motor neuron d…

…ers to teaching and implementing Shared Care Planning (SCP) for Amyotrophic Lateral Sclerosis (ALS) patients in Argentina.Objective To identify barriers to t…

…iated with Parkinson’s disease (PD) risk, its relationship with amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA) remains unclear, partic…

…d Environmental exposures have been linked to increased risk of amyotrophic lateral sclerosis (ALS); however, their impact on disease progression remains unc…

…MAP2 as a new candidate cerebrospinal fluid (CSF) biomarker for amyotrophic lateral sclerosis (ALS).Methods We measured CSF levels of MAP2 and neurofilament …